Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.

The safety and pharmacokinetics of weekly dapsone and weekly dapsone plus pyrimethamine were examined in adult patients with human immunodeficiency virus infection who were at risk for pneumocystis pneumonia because of a prior episode or a CD4+ T-cell count less than 250 cells per mm3. Groups of pat...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Falloon, J, Lavelle, J, Ogata-Arakaki, D, Byrne, A, Graziani, A, Morgan, A, Amantea, M A, Ownby, K, Polis, M, Davey, R T
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1994
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284596/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7979291/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.7.1580
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!